… to determine more precisely the scope of cetuximab activity in recurrent and/or metastatic …
the intention-to-treat efficacy data from 3 Phase II cetuximab studies with a retrospective study …

… cetuximab efficacy in this cancer setting are still lacking. This review focuses on the mechanisms
of action of cetuximab… have been associated with cetuximab efficacy in HNSCC several …

… with SCCHN who received cetuximab-based SCAI after … of squamous cell cancer of the head
and neck (SCCHN). Reported … efficacy of salvage chemotherapy combined with cetuximab …

… study demonstrated that combining cetuximab with platinum/… squamous cell carcinoma of the
head and neck (R/M SCCHN) … biomarker for the efficacy of cetuximab plus platinum/5-FU as …

… cetuximab plus radiotherapy was included in this trial, the question of direct clinical evidence
of cisplatin compared to cetuximab … to estimate the efficacy of cetuximab plus radiotherapy …

… Based on the results obtained in head and neck cancer (Citation4), cetuximab has been …
This study aimed to determine the efficacy and toxicity of a combined therapy of cetuximab …

… receiving cetuximab and 29 patients treated without cetuximab were … cetuximab group versus
three (10.3%) in the non-cetuximab group obtained after matching (P = 0.0275). Cetuximab …

… -cell carcinoma of the head and neck. We investigated the efficacy of cetuximab plus
platinum-… in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck. …

… to evaluate the safety and efficacy of cetuximab-containing … SCCHN who underwent
cetuximab-containing regimens after … cetuximab, and 1 carboplatin and fluorouracil and cetuximab …

… To date, the only survival benefit was seen with cetuximab, an … , was added to either cetuximab
or erlotinib in patients with … phase II evaluation of cetuximab alone versus cetuximab plus …